Ghent, 14th September 2023.
We are proud to part of the thriving community of life sciences, medtech, and digitech experts within the healthcare cluster of Ghent.
This flourishing ecosystem has been featured in an article in Labiotech, which highlights the seamless cooperation across companies, academic institutions, research centres, and healthcare facilities within Ghent.
Read the whole article here to explore the synergy between biotechnology, medical technology, and digital health in Ghent, a thriving European hub for technological innovation – including the exciting contributions of BioLizard.
If you’d like to learn more about how BioLizard can help you with all your data needs, reach out to us today. Let’s transform your data into actionable insights together!
Oncology drug development often begins in patients, allowing early safety and efficacy insights. Yet many cancer drugs still fail in the clinic. We validate the target but ignore its context within the tumor microenvironment. This article explores why spatial biology may improve clinical success.
BioLizard has been named “Bioinformatics Innovation of the Year” in the 2025 BioTech Breakthrough Awards. The honor spotlights Bio|Verse® Navigator, a visual analytics workspace that unifies complex R&D data so scientists can decide faster, with confidence.
Bioinformatics pipelines break for the smallest reasons: package updates, shifting dependencies, or “it only works on my machine.” This post explains why experienced software engineers and DevOps practices (Git, CI/CD, IaC) are essential to keep workflows reproducible, stable, and scalable.
